MedicalJane

JUNE 29, 2018

Pennsylvania’s neighboring state, Maryland , has a much shorter list of qualifying medical conditions: cachexia, anorexia, wasting syndrome, severe pain or nausea or persistent muscle spasms, seizures, glaucoma, PTSD, and chronic pain. Can your current doctor “prescribe” cannabis?

Patients 83

Patients Legalization Conditions Treatment 83

Cannabis Law Report

JULY 9, 2021

Drug Enforcement Agency (“DEA”). Some physicians and therapists have argued that the Right to Try Act permits them to administer psilocybin to terminally ill patients (since studies are well past the Phase 1 stage), but the DEA has met this with resistance given psilocybin’s status as a Schedule I drug. AIMS Institute, PLLC.

Law 81

Law Therapy Clinical Trials Research and Development 81

Cannabis Law Report

SEPTEMBER 23, 2019

Cannabis use, both medically and recreationally, is prevalent throughout history. 26 Evidence is most substantial for nausea and vomiting associated with chemotherapy, chronic pain treatment, multiple sclerosis spasticity, and intractable seizures associated with Dravet syndrome and Lennox-Gastaut syndrome. Background.

Cannabinoids 40

Cannabinoids Marijuana Research and Development Access 40

Veriheal

AUGUST 31, 2020

and farmers are required to have their crops tested at various labs registered with the Drug Enforcement Administration (DEA), but there are not enough labs to meet the demand for testing. . Supply chains are disrupted as a result, and consumers grow fearful of buying hemp. Personal data and information would be anonymous.

Research and Development 119

Research and Development Education Agriculture Patients 119

Cannabis Law Report

SEPTEMBER 19, 2019

CBD does not create the same high as THC and can be used for chronic pain and anxiety relief, according to Harvard Medical School. Both hemp and marijuana can be used to create CBD extracts, but hemp has a higher concentration of the compound. Both hemp and marijuana have extreme physical similarities.

Vaping 55

Vaping Hemp Education Patients 55

The Cannigma

SEPTEMBER 12, 2021

Marijuana (defined in the US as any cannabis plant where THC>0.3%) is a schedule I drug according to the DEA and FDA. If you have a family history of addiction, or suffer from mental conditions such as depression and schizophrenia, you should carefully consider whether or not cannabis is right for you, particularly Type I cannabis.

THC 98

THC Research and Development Cannabinoids CBD 98

Veriheal

NOVEMBER 7, 2024

The Drug Enforcement Administration (DEA) announced in August that a hearing regarding the reclassification decision will take place on December 2, 2024, before an administrative law judge. Then, the DEA will review the report and draft a final ruling, factoring in all relevant information submitted during the public comment period.

DEA 97

DEA Policy Chronic Pain Marijuana 97